- Published on
Emergency And Acute Medicine – Salicylate Poisoning
Salicylate poisoning is a serious toxicologic condition characterized by a mixed respiratory alkalosis and metabolic acidosis. This occurs due to stimulation of the respiratory center (causing hyperventilation) and disruption of cellular metabolism through inhibition of the Krebs cycle and uncoupling of oxidative phosphorylation. The result is increased acid production and impaired energy utilization. Additional metabolic disturbances include dehydration, hyponatremia or hypernatremia, hypokalemia, and hypocalcemia, largely due to vomiting, sweating, and tachypnea. Severe toxicity may lead to noncardiogenic pulmonary edema caused by direct endothelial injury. Importantly, in overdose, salicylate metabolism shifts from first-order to zero-order kinetics, meaning small increases in dose can lead to disproportionately large increases in serum levels.
Salicylate toxicity can occur from a variety of sources, most commonly aspirin ingestion. Toxicity is dose-dependent, with ingestions greater than 150 mg/kg considered potentially serious and those above 300 mg/kg potentially life-threatening. Other sources include oil of wintergreen (methyl salicylate), which is highly concentrated and dangerous even in small amounts, as well as bismuth subsalicylate and salsalate. In children, even small exposures can be dangerous, and toxicity tends to develop more rapidly and severely. In contrast to adults, children may not exhibit the classic early respiratory alkalosis and instead may present early with metabolic acidosis and hypoglycemia. In elderly patients, diagnosis may be delayed due to comorbidities, and symptoms such as altered mental status or respiratory distress often indicate severe toxicity.
Clinically, patients present with gastrointestinal symptoms such as nausea, vomiting, epigastric pain, and sometimes hematemesis. Pulmonary manifestations include tachypnea and, in severe cases, pulmonary edema. Neurologic symptoms are characteristic and include tinnitus (an early sign), hearing loss, confusion, delirium, seizures, and coma. A careful history is essential, as patients may not recognize aspirin as a medication or may confuse it with other over-the-counter drugs.
Diagnosis relies on serial salicylate levels and clinical assessment. Levels should be obtained at presentation and repeated every 2 hours until a clear downward trend is established, as delayed absorption (especially with enteric-coated preparations) can lead to rising levels after initial decline. Severity is best assessed clinically rather than relying solely on serum levels, as no reliable nomogram exists. Laboratory evaluation typically reveals a mixed acid–base disorder with respiratory alkalosis and anion-gap metabolic acidosis. Additional findings may include hypokalemia, renal dysfunction, and elevated anion gap. Imaging such as abdominal radiographs may identify pill concretions, and chest radiographs may detect pulmonary edema.
Management begins with stabilization of airway, breathing, and circulation. However, maintaining spontaneous respiration is critical, as patients rely on hyperventilation to compensate for acidosis. Premature intubation can worsen acidemia and should be avoided unless absolutely necessary. Initial therapy includes intravenous fluids (normal saline) for dehydration and hypotension, along with glucose, thiamine, and naloxone in patients with altered mental status.
Gastrointestinal decontamination with activated charcoal is recommended in alert patients. Whole-bowel irrigation may be considered in cases of sustained-release ingestion or visible concretions. The cornerstone of enhanced elimination is urinary alkalinization using intravenous sodium bicarbonate. This increases salicylate ionization, reducing tissue penetration and enhancing renal excretion. The goal is a urine pH of 7.5–8.0, while maintaining adequate potassium levels to support alkalinization.
Hemodialysis is indicated in severe cases, including patients with pulmonary edema, altered mental status, severe acid–base disturbances, renal failure, or unstable vital signs. It is also considered when salicylate levels exceed 80–100 mg/dL in acute ingestion, though clinical status is more important than absolute level. The threshold for dialysis is lower in chronic toxicity.
Patients require admission for monitoring if salicylate levels exceed 25 mg/dL or if symptoms are present. ICU care is indicated for severe toxicity. Discharge is appropriate only when levels fall below 25 mg/dL and symptoms resolve. Patients with intentional overdose should receive psychiatric evaluation, while those with chronic exposure require close outpatient follow-up.
A key clinical pearl is that patients must maintain their respiratory drive to compensate for metabolic derangements; thus, unnecessary intubation can be dangerous. Additionally, salicylate levels may initially decline and then rise again due to delayed absorption, so serial monitoring is essential. Toxicity may also occur from non-oral exposures such as topical preparations or suppositories, underscoring the importance of a thorough history.
0 Comments
